The Hand, Foot and Mouth Disease drugs in development market research report provides comprehensive information on the therapeutics under development for Hand, Foot and Mouth Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Hand, Foot and Mouth Disease. Buy the report here.
Smarter leaders trust GlobalData
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Hand, Foot and Mouth Disease and features dormant and discontinued products.
GlobalData tracks 24 drugs in development for Hand, Foot and Mouth Disease by 22 companies/universities/institutes. The top development phase for Hand, Foot and Mouth Disease is preclinical with ten drugs in that stage. The Hand, Foot and Mouth Disease pipeline has 16 drugs in development by companies and eight by universities/ institutes. Some of the companies in the Hand, Foot and Mouth Disease pipeline products market are: Chongqing Zhifei Biological Products, Griffith University and Institut Pasteur of Shanghai Chinese Academy of Sciences.
The key targets in the Hand, Foot and Mouth Disease pipeline products market include Collagen, Dual Specificity Mitogen Activated Protein Kinase Kinase 1, and RNA.
The key mechanisms of action in the Hand, Foot and Mouth Disease pipeline product include Dual Specificity Mitogen Activated Protein Kinase Kinase 1 Inhibitor with one drug in Discovery. The Hand, Foot and Mouth Disease pipeline products include seven routes of administration with the top ROA being Parenteral and seven key molecule types in the Hand, Foot and Mouth Disease pipeline products market including Small Molecule, and Subunit Vaccine.
Hand, Foot and Mouth Disease overview
Hand, foot and mouth disease (HFMD) is an illness that causes sores in or on the mouth and on the hands, feet, and legs. Hand, foot and mouth disease is most commonly caused by coxsackievirus A16, a member of the enterovirus family. Symptoms include fever, headache, loss of appetite, and ulcers in the throat (including tonsils), mouth, and tongue. Treatment includes antibiotics and pain relievers.
For a complete picture of Hand, Foot and Mouth Disease’s pipeline drug market, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.
